Literature DB >> 12678697

Development and application of fluorescence polarization assays in drug discovery.

T J Burke1, K R Loniello, J A Beebe, K M Ervin.   

Abstract

Fluorescence polarization technology has been used in basic research and commercial diagnostic assays for many decades, but has begun to be widely used in drug discovery only in the past six years. Originally, FP assays for drug discovery were developed for single-tube analytical instruments, but the technology was rapidly converted to high-throughput screening assays when commercial plate readers with equivalent sensitivity became available. This review will discuss fluorescence polarization assays in current use in drug discovery research as well as those in development that will likely be used in the near future. These assays include targets such as kinases, phosphatases, proteases, G-protein coupled receptors, and nuclear receptors.

Mesh:

Substances:

Year:  2003        PMID: 12678697     DOI: 10.2174/138620703106298365

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  24 in total

1.  A high-throughput assay for Tn5 Tnp-induced DNA cleavage.

Authors:  Brandon Ason; William S Reznikoff
Journal:  Nucleic Acids Res       Date:  2004-06-16       Impact factor: 16.971

Review 2.  Exploring biology with small organic molecules.

Authors:  Brent R Stockwell
Journal:  Nature       Date:  2004-12-16       Impact factor: 49.962

3.  Biomolecular interaction analysis in functional proteomics.

Authors:  D Moll; A Prinz; F Gesellchen; S Drewianka; B Zimmermann; F W Herberg
Journal:  J Neural Transm (Vienna)       Date:  2006-07-13       Impact factor: 3.575

4.  High-throughput identification of inhibitors of human mitochondrial peptide deformylase.

Authors:  Christophe Antczak; David Shum; Sindy Escobar; Bhramdeo Bassit; Earl Kim; Venkatraman E Seshan; Nian Wu; Guangli Yang; Ouathek Ouerfelli; Yue-Ming Li; David A Scheinberg; Hakim Djaballah
Journal:  J Biomol Screen       Date:  2007-04-13

5.  A high throughput fluorescence polarization assay for inhibitors of the GoLoco motif/G-alpha interaction.

Authors:  Adam J Kimple; Adam Yasgar; Mark Hughes; Ajit Jadhav; Francis S Willard; Robin E Muller; Christopher P Austin; James Inglese; Gordon C Ibeanu; David P Siderovski; Anton Simeonov
Journal:  Comb Chem High Throughput Screen       Date:  2008-06       Impact factor: 1.339

6.  Development of a pterin-based fluorescent probe for screening dihydropteroate synthase.

Authors:  Ying Zhao; Dalia Hammoudeh; Wenwei Lin; Sourav Das; Mi-Kyung Yun; Zhenmei Li; Elizabeth Griffith; Taosheng Chen; Stephen W White; Richard E Lee
Journal:  Bioconjug Chem       Date:  2011-09-30       Impact factor: 4.774

7.  Identification of influenza endonuclease inhibitors using a novel fluorescence polarization assay.

Authors:  Brandi M Baughman; P Jake Slavish; Rebecca M DuBois; Vincent A Boyd; Stephen W White; Thomas R Webb
Journal:  ACS Chem Biol       Date:  2012-01-19       Impact factor: 5.100

8.  Probing the human estrogen receptor-α binding requirements for phenolic mono- and di-hydroxyl compounds: a combined synthesis, binding and docking study.

Authors:  Christopher McCullough; Terrence S Neumann; Jayapal Reddy Gone; Zhengjie He; Christian Herrild; Julie Wondergem Nee Lukesh; Rajesh K Pandey; William A Donaldson; Daniel S Sem
Journal:  Bioorg Med Chem       Date:  2013-11-21       Impact factor: 3.641

9.  Multiplexing Fluorescence Anisotropy Using Frequency Encoding.

Authors:  Adrian M Schrell; Nikita Mukhitov; Michael G Roper
Journal:  Anal Chem       Date:  2016-08-02       Impact factor: 6.986

10.  Aryl acid adenylating enzymes involved in siderophore biosynthesis: fluorescence polarization assay, ligand specificity, and discovery of non-nucleoside inhibitors via high-throughput screening.

Authors:  João Neres; Daniel J Wilson; Laura Celia; Brian J Beck; Courtney C Aldrich
Journal:  Biochemistry       Date:  2008-10-18       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.